Article
Early Treatment of Interleukin-33 Can Attenuate Lupus Development in Young NZB/W F1 Mice
2020-10-12
Abstract excerpt
Interleukin-33 (IL-33), a member of the IL-1 cytokine family has been recently associated with the development of autoimmune diseases, including SLE. IL-33 is an alarmin and a pleiotropic cytokine that affects various types of immune cells via binding to its receptor, ST2. In this study, we determine the impact of intraperitoneal IL-33 treatments in young lupus, NZB/W F1 mice. Mice were treated from the age of 6 t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c5343e34-30c2-594c-8474-01736cfbeeac
- DOI
- 10.20944/preprints202010.0246.v1
